β Home
Stryker Corp
-14.9%
Healthcare & biotech / Orthopedics, medical and surgical, and neurotechnology and spine applications
βΉοΈ Info
π§Ύ At a Glance π Core Facts ποΈ Products/Services β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π Insights π’ Company Q&A (574) π οΈ Industry Q&A (121) π Competitors π Price Low π Price Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risk Assessment π§© Segmentation π Ά Google Linksπ Ratios
π° Margins π Financial Ratios π± Growth π Enterprise Value π Key Metrics π΅ Dividendsπ§ Tools
β Due Diligenceπ§© Revenue Segmentation by Product
Switch to Location
| Fiscal year | Segment | Value |
|---|---|---|
| 2025 | MedSurg | 15.65B |
| 2025 | Orthopaedics | 9.47B |
| 2024 | MedSurg | 13.52B |
| 2024 | Orthopaedics | 9.08B |
| 2024 | MedSurg and Neurotechnology | 13.52B |
| 2024 | Orthopaedics | 9.08B |
| 2023 | MedSurg | 11.84B |
| 2023 | Orthopaedics and Spine | 8.66B |
| 2023 | MedSurg and Neurotechnology | 11.84B |
π° Explore more revenue segmentation data for Stryker Corp!
Sign up for free or log inπ Your free copy of "The Checklist Value Investor β A Smarter Way to Pick Stocks" is waiting